Jun. 11 at 7:17 PM
$CELZ Should be releasing the second cohort of CELZ-201 DDT very soon for lower back pain, including for degenerative disc disease. The addressable market is one of the largest in the world. IF the results are great, which they should be, this will be heading to Phase 3 for a treatment that gets away from opioids and other addictive drugs with major side effects, all with much better efficacy and RFK is HHS Chief and a huge advocate for non-opiod treatments. Could be like
$VTGN in 2023 when they released their first positive Phase 3 data for non-SSRI treatment for SAD and other anxiety disorders.
